David Lovejoy

No más puestos en curso

Fortuna: 49 104 $ al 31/05/2024

Health Technology

Consumer Services

Antiguos cargos conocidos de David Lovejoy.

Empresas	Cargo	Inicio	Fin
University of Toronto	Corporate Officer/Principal	-	-
PROTAGENIC THERAPEUTICS, INC.	Director Técnico/Científico/I+D	03/02/1994	-
PROTAGENIC THERAPEUTICS, INC.	Fundador	03/02/1994	-
Protagenic Therapeutics, Inc. /Old/ Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY.	Director Técnico/Científico/I+D	-	-

University of Victoria

Doctorate Degree

Internacional

Estados Unidos	3
Canadá	3

Operativa

Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1
Corporate Officer/Principal	1

Sectorial

Health Technology	3
Consumer Services	3

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
PROTAGENIC THERAPEUTICS, INC.	Health Technology

Empresas privadas	1
Protagenic Therapeutics, Inc. /Old/ Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY.	Health Technology

Empresas privadas

Health Technology